FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Wei Binxian

 2. Date of Event Requiring Statement (MM/DD/YYYY)
2/10/2019 

 3. Issuer Name and Ticker or Trading Symbol

Neuralstem, Inc. [CUR]

(Last)        (First)        (Middle)

20271 GOLDENROD LANE, 2ND FLOOR

 4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                          _____ 10% Owner
_____ Officer (give title below)        _____ Other (specify below)

(Street)

GERMANTOWN, MD 20876      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)

7/3/2019 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		2. Amount of Securities Beneficially Owned
(Instr. 4)		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)		2. Date Exercisable and Expiration Date
(MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Common Stock Purchase Option (1)(3)7/1/2019 7/1/2029 Common Stock 20212 (2)$6.002 (2)D  
Explanation of Responses:
(1) Represents 100% of compensatory Annual Grant for director services equal to $100,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/,20 and 6/30/20.
(2) All exercise prices and share amounts reported in this Form 4/A reflect a 1-for-20 reverse split that occurred on July 17, 2019.
(3) This amendment is being filed to correct a scrivener's error with regard to the option amount previously reported.
Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Wei Binxian
20271 GOLDENROD LANE, 2ND FLOOR
GERMANTOWN, MD 20876		X
Signatures
/s/ Binxian Wei10/11/2019
**Signature of Reporting PersonDate
Neuralstem (NASDAQ:CUR)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024 Click aqui para mais gráficos Neuralstem.
Neuralstem (NASDAQ:CUR)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024 Click aqui para mais gráficos Neuralstem.